Navigation Links
NeuroSigma Announces FDA Approval to Commence Phase III Trial
Date:7/29/2013

LOS ANGELES, July 29, 2013 /PRNewswire/ -- NeuroSigma, Inc., today announced conditional approval by the U.S. Food and Drug Administration (FDA) of its Investigational Device Exemption (IDE) application to commence a Phase III pivotal trial of the Monarch™ eTNS™ System for treatment of drug resistant epilepsy.  The Company is planning to conduct a multi-center trial at leading medical institutions in the U.S., Europe and Canada.  The objective of the study is to evaluate the safety and effectiveness of the device and provide the basis for a Pre‐Market Approval (PMA) application to the FDA.

In earlier Phase 1 and Phase 2 clinical trials of external Trigeminal Nerve Stimulation (eTNS), over 40% of patients treated showed a 50% or greater reduction in seizures.  "We are eager to take this next key step in the regulatory approval process of eTNS in the United States," said Leon Ekchian, Ph.D., President and CEO of NeuroSigma.  "We believe a safe, non-invasive and affordable alternative to pharmaceuticals and invasive treatments is urgently needed by the 50-million people with epilepsy worldwide."

The Monarch eTNS System is currently available with a physician's prescription in the European Union and Canada as adjunctive treatment of epilepsy and depression, for adults and children 9 years and older.

About TNS and The Monarch eTNS System

The Monarch eTNS System is c
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
2. NeuroSigma Receives Global Quality Control Certification
3. NeuroSigma Receives CE Certification
4. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
5. NeuroSigma Awarded Fast Track SBIR Grant by the NIH for Development of Implantable sTNS System for Drug Resistant Epilepsy
6. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
7. NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System for the Treatment of Drug-Resistant Epilepsy and Major Depressive Disorder
8. NeuroSigma Launches Dedicated Website to Introduce Its Monarch eTNS System for Epilepsy and Depression
9. NeuroSigma Announces Debut of Its Monarch eTNS System in Canada
10. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
11. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 Research and ... the addition of the "Global Next Generation ... The global next generation sequencing market ... the period 2014-2019 This report covers ... the global next generation sequencing market for the ...
(Date:5/21/2015)... SEATTLE , May 21, 2015 Sarcos ... sensors and medical devices, announced today the appointment of ... Officer and head of Corporate Development effective immediately.  Woo ... development and finance roles, including positions at UBS Investment ... Woo will be located in Sarcos, Seattle ...
(Date:5/21/2015)... , May 21, 2015 /CNW/ - Canadians face wait times of ... lifesaving medicines in public drug plans, according to a new ... Canada 16 out of 18 similar OECD ... 23% of 141 Health Canada-approved new medicines were included in public ... on this front," said Brett Skinner , Rx&D Executive Director, ...
Breaking Medicine Technology:Global Next Generation Sequencing Market 2015-2019 2Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2Canadians lagging well behind similar countries on access to new medicines: report 2Canadians lagging well behind similar countries on access to new medicines: report 3
... N.Y. Feb. 7, 2011 BioSpecifics Technologies Corp. (Nasdaq: ... biopharmaceutical company developing first in class collagenase-based products, today ... Rights Agreement (the "Rights Agreement"), adopted May 14, 2002 ... The Amendment increases the ownership threshold for determining ...
... start-up, UrgentRx , today announced the launch of ... credit card-sized packets, including UrgentRx Aspirin to Go ... first aid.  February is the American Heart Association,s ... UrgentRx Aspirin to Go timely as research supports the ...
Cached Medicine Technology:UrgentRx Launches Line of Innovative and Portable, Fast-Acting Medications Across Colorado 2UrgentRx Launches Line of Innovative and Portable, Fast-Acting Medications Across Colorado 3
(Date:5/22/2015)... 2015 The dentist in ... that they are now offering complimentary consultations to ... treatments. At consultations, patients can discuss their candidacy ... certain treatments can achieve and whether alternative options ... initial appointment. If treatments are chosen, patients can ...
(Date:5/22/2015)... 22, 2015 Wimbledon Health Partners, the ... (EKG), echocardiogram and NCV testing , is proud ... respected All American National athlete, to the Wimbledon Athletics ... the high level of testing and information it provides ... their athletic trainers, this way they can focus on ...
(Date:5/22/2015)... May 22, 2015 In April 2006, ... the past 9 years they have concentrated their focus ... States and Canada. Because of this growth and their ... corporate offices in Denver, Colorado, Cleveland, Ohio, Houston, Texas ... in opening new dental offices, dental start ups, orthodontic ...
(Date:5/22/2015)... May 22, 2015 In efforts to ... the section containing particular muscles stretches has been a ... 50% of stretches now complete, Chunk Fitness envisions a ... to be filmed and released at a later point ... found here: http://www.chunkfitness.com/stretches . , About the Company: ...
(Date:5/21/2015)... New York, New York (PRWEB) May 21, 2015 ... and distributor of patented products, launches the Troll Motor ... more convenient way of boating. , "The recreational boating ... says Scott J. Cooper, CEO and Creative Director of ... the water in record numbers and predicts continued steady ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3
... ... and distribute the QuickMAR e-charting software with its electronic medication management systems. , ... (PRWEB) January 26, 2010 ... easily and accurately manage patient medications, with today’s announcement of a joint distribution agreement ...
... publication in The Endocrine Society,s Journal of Clinical ... commonly used forms of antidepressant drugs may experience delayed ... to achieve their breastfeeding goals. Breastfeeding benefits ... milk is easy to digest and contains antibodies that ...
... ... tips for safer driving on icy highways. , ... New York, NY (PRWEB) January 26, 2010 -- When rain falls or ... personal injury attorney says., , ,“Black ice is as dangerous as it is difficult to ...
... ... is pleased to announce that they are now offering Trek’s Ride+ electric assist bikes to their ... and battery, Trek Travel is opening up a new world of cycling vacations to a wider ... ...
... ... an industry leader in Continuous Process Improvement (CPI) Training and Certification, took ... battle tough economic times, they made their On Demand Lean Six Sigma ... hundreds of organizations to learn the basics of Lean Six Sigma, but ...
... , , WASHINGTON , Jan. 25 ... guilty today for her role in a Detroit -area home ... of the Criminal Division; U.S. Attorney for the Eastern District ... Arena of the FBI,s Detroit Field Office; and Special Agent in ...
Cached Medicine News:Health News:Medicine-On-Time Partners With QuickMAR to Streamline Medication Management and Improve Patient Care 2Health News:Medicine-On-Time Partners With QuickMAR to Streamline Medication Management and Improve Patient Care 3Health News:Common antidepressant drugs linked to lactation difficulties in moms 2Health News:Driving Danger -- Black Ice Poses Menace on Frigid NY Roadways, New York Attorney Steven J. Schwartzapfel Says 2Health News:Driving Danger -- Black Ice Poses Menace on Frigid NY Roadways, New York Attorney Steven J. Schwartzapfel Says 3Health News:Driving Danger -- Black Ice Poses Menace on Frigid NY Roadways, New York Attorney Steven J. Schwartzapfel Says 4Health News:Trek Travel Introduces Trek's Ride+ Electric Assist Bikes to Cycling Vacations 2Health News:Mountain Home Experiences a Huge Response to Their Ground Breaking Free Lean Six Sigma Certification Offer 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 3
... ENA Profile-6 ELISA test system is a ... antibodies to Jo-1, Sm, Sm/RNP, SSA, SSB, ... according to the directional insert, the results ... the diagnosis and treatment of autoimmune connective ...
Inquire...
... The K-ASSAY Microalbumin Urine Controls ... to use liquid requiring no ... prepared from human urine, fortified ... albumin and creatinine. Preservatives including ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: